- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05032378
Motion Sensor and Feedback System Efficacy to Refine Movements After Injury
Efficacy of a Motion Sensor and Feedback System to Refine Movements of People With Acquired Neurological Injury: A Series of Case Studies
Study Overview
Status
Detailed Description
People with acquired neurological disorders often exhibit impaired movement patterns when performing functional activities such as walking, standing up from a seated position, and reaching for objects. Re-establishing normal movement patterns is an essential part of rehabilitation; however, achievement of this typically requires thousands of accurate movement repetitions. Only through this repetition can a person benefit from the inherent neuroplasticity of the nervous system to make restored patterns habitual.
Sensory and/or proprioceptive problems may limit a person's awareness of ways in which abnormal movement patterns differ from desired ones. Because of these problems, provision of external feedback in the form of verbal comments, physical repositioning of the limbs by another person, or other auditory or haptic cues is critical. As a general rule, a person benefits most when provided with precise feedback about the position of body parts when he/she is actively engaged in performing a desired movement. As such, the linking of motion sensors programmed to detect achievement of a target position with immediate auditory (i.e., beeps) and/or haptic (i.e., vibrations) feedback has the potential to be a powerful treatment tool.
The Kinesthetic Awareness Training (KAT) device developed by PantherTec is a wearable, motion capture system that can be programmed to detect and provide immediate auditory and/or haptic feedback when a person moves a specified body part to a target position during performance of a functional sequence of movements. Each time a person replicates the desired movement, the device either begins emitting or ceases emitting beeps and/or vibrations-as specified during programming-to indicate achievement of the correct position. Adjustment of the sensitivity (i.e., margin of error per target value) allows for specification of how close a performed movement must be to the target position to elicit feedback.
PantherTec has made a prototype of the KAT device available to Quality Living, Inc. (QLI) for feasibility testing and exploration of possible applications with people with movement impairments resulting from acquired neurological injury. The purpose of the proposed case studies is to determine the efficacy of the KAT device in facilitating the restoration of desired movement patterns when people with acquired central nervous system damage perform functional activities such as walking, transitioning from one position to another, or reaching with the arms.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Karen Hux, Ph.D.
- Phone Number: 402-574-2838
- Email: karen.hux@qliomaha.com
Study Contact Backup
- Name: Megan Potter, DPT
- Phone Number: 402-573-3700
- Email: megan.potter@qliomaha.com
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68104
- Quality Living, Inc.
-
Contact:
- Karen Hux, Ph.D.
- Phone Number: 402-574-2838
- Email: karen.hux@qliomaha.com
-
Contact:
- Megan Potter, DPT
- Phone Number: 402-573-3700
- Email: megan.potter@qliomaha.com
-
Principal Investigator:
- Karen Hux, Ph.D.
-
Sub-Investigator:
- Megan Potter, DPT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Current residents of Quality Living, Inc., who are receiving treatment for an acquired movement disorder.
Current staff of Quality Living, Inc., who are providing physical or occupational therapy treatment to a participant with an acquired movement disorder.
Description
Inclusion Criteria:
For participants with movement disorders:
- Between 16 and 70 years of age
- Has an acquired movement disorder secondary to neurological injury
- Understands English sufficiently to follow simple commands
- Is a current resident of Quality Living, Inc.
For professionals:
- Over 19 years of age
- A physical therapy or occupational therapy staff member employed by Quality Living, Inc.
- Has used the KAT device to provide treatment to a participant with a movement disorder
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
People with movement disorders
Adults with acquired movement disorders secondary to neurological injury.
|
One physical or occupational therapy session per week for 8 weeks during which the participant with disordered movement will attempt to perform desired movements while wearing the KAT device
Other Names:
|
Professionals
Professionals providing physical or occupational therapy to participants with acquired movements disorders.
|
Physical or occupational therapy professionals will provide one KAT-assisted therapy session per week for 8 weeks to one or more participants with movement disorder.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Goal Attainment Scaling (GAS) in rehabilitation
Time Frame: completion of 8-week treatment period
|
The GAS uses a 5-point rating scale to describe the extent of a participant's goal achievement.
Scores for each attainment goal range from -2 (much worse than expected) to +2 (much better than expected).
The composite GAS (the sum of attainment levels x the relative weight for each goal) is transformed into a standardized measure or T score with a mean of 50 and standard deviation of 10.
|
completion of 8-week treatment period
|
System Usability Scale (SUS)
Time Frame: completion of 8-week treatment provision period
|
The SUS is a feasibility rating scale for that will be used by professional participants to evaluate the KAT device.
It includes 10 items with 5 response options ranging from 1 (strongly disagree) to 5 (strongly agree).
Scores for odd-numbered items on the scale are calculated by subtracting 1 from the user's rating; scores for even-numbered items on the scale are calculated by subtracting the user's response from 5.
This scales all values from 0 to 4, with four being the most positive response.
Summing the converted scores and multiplying by 2.5 yields a score between 0 and 100, with 100 being the most positive score.
|
completion of 8-week treatment provision period
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KAT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Kinesthetic Awareness Training
-
Izmir Katip Celebi UniversityCompleted
-
Smith-Kettlewell Eye Research InstituteRecruitingBlindness | Low Vision | Blindness, Acquired | Blindness, CompleteUnited States
-
Istanbul Medipol University HospitalNot yet recruiting
-
Kutahya Health Sciences UniversityRecruitingExercise | Cognitive Function | Healthy Participants | Motor Activity | Cognitive Rehabilitation | Balance, Postural | Multi-Tasking Behavior | Imagery, Psychotherapy | Stroop Test | Cognitive TestTurkey
-
William D. KillgoreUnited States Department of DefenseCompleted
-
Ufuk UniversityUnknownOsteoarthritis | Gait Disorders, Neurologic
-
Hacettepe UniversityUnknown
-
Riphah International UniversityRecruitingKnee OsteoarthritisPakistan
-
C. Michael DunhamSt. Elizabeth Youngstown HospitalCompletedStress | Stress, Psychological | ElectroencephalographyUnited States
-
Maltepe UniversityRecruiting